Effect of Cyclodextrin Complex Formation on Solubility Changes of Each Drug Due to Intermolecular Interactions Between Acidic NSAIDs and Basic H2 Blockers

Overview

Journal Mol Pharm

Publisher American Chemical Society

Specialty Pharmacology

Date 2023 Sep 9

PMID 37688787

Authors

Chihiro Tsunoda

Kanji Hasegawa

Ryosuke Hiroshige

Takahiro Kasai

Hideshi Yokoyama

Satoru Goto

Affiliations

Soon will be listed here.

Abstract

One of the solubilization of poorly water-soluble drugs is the use of cyclodextrin (CD)-based inclusion complexes. On the other hand, few studies have investigated how CD functions on the solubility of drugs in the presence of multiple drugs that interact with each other. In this study, we used indomethacin (IND) and diclofenac (DIC) as acidic drugs, famotidine (FAM) and cimetidine (CIM) as basic drugs, and imidazole (IMZ), histidine (HIS), and arginine (ARG) as compounds structurally similar to basic drugs. We attempted to clarify the effect of β-CD on the solubility change of each drug in the presence of multiple drugs. IND and DIC formed a eutectic mixture in the presence of CIM, IMZ, and ARG, which greatly increased the intrinsic solubility of the drugs as well as their affinity for β-CD. Furthermore, the addition of high concentrations of β-CD to the DIC-FAM combination, which causes a decrease in solubility due to the interaction, improved the solubility of FAM, which was decreased in the presence of DIC. These results indicate that β-CD synergistically improves the solubility of drugs in drug-drug combinations, where the solubility is improved, whereas it effectively improves the dissolution rate of drugs in situations where the solubility is reduced by drug-drug interactions, such as FAM-DIC. This indicates that β-CD can be used to improve the physicochemical properties of drugs, even when they are administered in combination with drugs that interact with each other.

Citing Articles

Significantly improving the solubility and anti-inflammatory activity of fenofibric acid with native and methyl-substituted beta-cyclodextrins via complexation.

Rajamohan R, Muthuraja P, Murugavel K, Mani M, Prabakaran D, Seo J Sci Rep. 2025; 15(1):853.

PMID: 39757237 PMC: 11701116. DOI: 10.1038/s41598-024-84745-x.

How Does the Powder Mixture of Ibuprofen and Caffeine Attenuate the Solubility of Ibuprofen? Comparative Study for the Xanthine Derivatives to Recognize Their Intermolecular Interactions Using Fourier-Transform Infrared (FTIR) Spectra, Differential....

Suenaga S, Kataoka H, Hasegawa K, Koga R, Tsunoda C, Kuwashima W Mol Pharm. 2024; 21(9):4524-4540.

PMID: 39109552 PMC: 11487632. DOI: 10.1021/acs.molpharmaceut.4c00429.

References

Koneru B, Cowart D, Noorisa M, Kisicki J, Bramer S . Effect of increasing gastric pH with famotidine on the absorption and oral pharmacokinetics of the inotropic agent vesnarinone. J Clin Pharmacol. 1998; 38(5):429-32. DOI: 10.1002/j.1552-4604.1998.tb04448.x. View

Brouwers J, Brewster M, Augustijns P . Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?. J Pharm Sci. 2009; 98(8):2549-72. DOI: 10.1002/jps.21650. View

Yamao J, Kikuchi E, Matsumoto M, Nakayama M, Ann T, Kojima H . Assessing the efficacy of famotidine and rebamipide in the treatment of gastric mucosal lesions in patients receiving long-term NSAID therapy (FORCE--famotidine or rebamipide in comparison by endoscopy). J Gastroenterol. 2007; 41(12):1178-85. DOI: 10.1007/s00535-006-1952-5. View

Yamamura S, Gotoh H, Sakamoto Y, Momose Y . Physicochemical properties of amorphous precipitates of cimetidine-indomethacin binary system. Eur J Pharm Biopharm. 2000; 49(3):259-65. DOI: 10.1016/s0939-6411(00)00060-6. View

van Leeuwen R, van Gelder T, Mathijssen R, Jansman F . Drug-drug interactions with tyrosine-kinase inhibitors: a clinical perspective. Lancet Oncol. 2014; 15(8):e315-26. DOI: 10.1016/S1470-2045(13)70579-5. View

Varnai B, Malanga M, Sohajda T, Beni S . Molecular interactions in remdesivir-cyclodextrin systems. J Pharm Biomed Anal. 2021; 209:114482. PMC: 8609759. DOI: 10.1016/j.jpba.2021.114482. View

Satoh H, Akiba Y, Urushidani T . Proton Pump Inhibitors Prevent Gastric Antral Ulcers Induced by NSAIDs via Activation of Capsaicin-Sensitive Afferent Nerves in Mice. Dig Dis Sci. 2020; 65(9):2580-2594. DOI: 10.1007/s10620-020-06157-x. View

Challa R, Ahuja A, Ali J, Khar R . Cyclodextrins in drug delivery: an updated review. AAPS PharmSciTech. 2005; 6(2):E329-57. PMC: 2750546. DOI: 10.1208/pt060243. View

Szente L, Puskas I, Sohajda T, Varga E, Vass P, Nagy Z . Sulfobutylether-beta-cyclodextrin-enabled antiviral remdesivir: Characterization of electrospun- and lyophilized formulations. Carbohydr Polym. 2021; 264:118011. PMC: 8025548. DOI: 10.1016/j.carbpol.2021.118011. View

10.

Salustio P, Feio G, Figueirinhas J, Pinto J, Cabral Marques H . The influence of the preparation methods on the inclusion of model drugs in a beta-cyclodextrin cavity. Eur J Pharm Biopharm. 2008; 71(2):377-86. DOI: 10.1016/j.ejpb.2008.09.027. View

11.

Loftsson T, Brewster M . Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci. 1996; 85(10):1017-25. DOI: 10.1021/js950534b. View

12.

Pineiro A, Pipkin J, Antle V, Garcia-Fandino R . Aggregation versus inclusion complexes to solubilize drugs with cyclodextrins. A case study using sulphobutylether-β-cyclodextrins and remdesivir. J Mol Liq. 2021; 343:117588. PMC: 8447550. DOI: 10.1016/j.molliq.2021.117588. View

13.

Midao L, Giardini A, Menditto E, Kardas P, Costa E . Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe. Arch Gerontol Geriatr. 2018; 78:213-220. DOI: 10.1016/j.archger.2018.06.018. View

14.

Taha A, Hudson N, Hawkey C, Swannell A, Trye P, Cottrell J . Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl J Med. 1996; 334(22):1435-9. DOI: 10.1056/NEJM199605303342204. View

15.

Meanwell N . Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety. Chem Res Toxicol. 2011; 24(9):1420-56. DOI: 10.1021/tx200211v. View

16.

Higashi K . [Solid State NMR Investigation for Molecular States of Specialized Formulation to Improve the Water Solubility of Poorly Water-soluble Drugs]. Yakugaku Zasshi. 2021; 141(9):1063-1069. DOI: 10.1248/yakushi.21-00124. View

17.

Davis M, Brewster M . Cyclodextrin-based pharmaceutics: past, present and future. Nat Rev Drug Discov. 2004; 3(12):1023-35. DOI: 10.1038/nrd1576. View

18.

Cogswell S, Berger S, Waterhouse D, Bally M, Wasan E . A parenteral econazole formulation using a novel micelle-to-liposome transfer method: in vitro characterization and tumor growth delay in a breast cancer xenograft model. Pharm Res. 2006; 23(11):2575-85. DOI: 10.1007/pl00022054. View

19.

Hattori Y, Haruna Y, Otsuka M . Dissolution process analysis using model-free Noyes-Whitney integral equation. Colloids Surf B Biointerfaces. 2012; 102:227-31. DOI: 10.1016/j.colsurfb.2012.08.017. View

20.

Aungst B . Optimizing Oral Bioavailability in Drug Discovery: An Overview of Design and Testing Strategies and Formulation Options. J Pharm Sci. 2016; 106(4):921-929. DOI: 10.1016/j.xphs.2016.12.002. View